ABU DHABI / GULF TIME As the world marks Sarcoma Awareness Month this July, leading ...
Read More »Takeda clinches $62 billion deal to buy drugmaker Shire
Bloomberg Takeda Pharmaceutical Co. reached an agreement to buy larger rival Shire Plc for about 46 billion pounds ($62 billion) in a deal that transforms it into a top drugmaker in the lucrative business of rare diseases and boosts its heft in the US. The Japanese company capped a drawn-out pursuit by agreeing to pay Shire 49.01 pounds a share ...
Read More »